Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
May 20 2021 - 6:09AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO
RULE 13a-16
OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT
OF 1934
For the month of May 2021
Commission file number: 001-38775
ITAMAR MEDICAL LTD.
(Name of registrant)
9 Halamish Street, Caesarea 3088900, Israel
(Address of principal executive office)
_____________________
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F x
Form 40-F ¨
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
____________________
EXPLANATORY NOTE
Itamar Medical Ltd. hereby
furnishes its investors presentation, which is attached to this Form 6-K as Exhibit 99.1.
Exhibits
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
ITAMAR MEDICAL LTD.
|
|
|
|
By:
|
/s/ Shy Basson
|
|
|
Shy Basson
Chief Financial Officer
|
Date: May 20, 2021
Itamar Medical (NASDAQ:ITMR)
Historical Stock Chart
From Aug 2024 to Sep 2024
Itamar Medical (NASDAQ:ITMR)
Historical Stock Chart
From Sep 2023 to Sep 2024